Corvus Pharmaceuticals, Inc. (CRVS) Social Stream



Corvus Pharmaceuticals, Inc. (CRVS): $3.58

-0.28 (-7.25%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CRVS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#142 of 382

in industry

CORVUS PHARMACEUTICALS INC (CRVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $6 $3.5 $5.125 $3.45 48.55%
2021-12-01 5 $8 $3.5 $5.7 $3.45 65.22%
2021-12-03 4 $8 $3.5 $6.375 $3.45 84.78%
2022-05-11 3 $8 $3.5 $6.375 $3.45 84.78%
2022-08-09 3 $8 $4 $6 $3.45 73.91%
2022-10-07 4 $8 $2 $5.333 $3.45 54.58%
2022-11-07 4 $6 $2 $3.333 $3.45 -3.39%
2022-12-14 3 $3 $2 $2.5 $3.45 -27.54%
2023-04-05 4 $3.5 $2 $2.833 $3.45 -17.88%
2023-05-09 4 $4 $3.5 $3.833 $3.45 11.1%
2023-05-29 4 $8 $3.5 $4.875 $3.45 41.3%
2023-05-30 4 $10 $3.5 $6.375 $3.45 84.78%

The Trend in the Analyst Price Target


Over the past 19 months, CRVS's average price target has gone up $1.25.

CRVS reports an average of 299.02% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-09 3 8 4 6.000 0.870 589.66%
2022-10-07 4 8 2 5.333 0.940 467.34%
2022-11-07 4 6 2 3.333 0.849 292.58%
2022-11-07 4 8 2 4.500 0.849 430.04%
2022-11-07 3 8 2 4.500 0.849 430.04%

CRVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


CRVS's average broker recommendation rating improved by 0 over the prior 17 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how CORVUS PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is higher than 101.15% of that group.
  • To contextualize these metrics, consider that out of all US stocks, CORVUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 307.1% of them.
  • In terms of how CORVUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1385.23% of that group.
  • CRVS has a greater upside potential (average analyst target price relative to current price) than 651.64% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, RLMD, PDSB, and EPIX are the three stocks most similar to CORVUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CRVS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7109 seconds.